
Pfizer's PFE.N shares rise 4.4% to $24.06
Stock set for its biggest single-day pct. jump in nearly 4 months, if gains hold
PFE posts Q1 adj. EPS of $0.92, beating analysts' estimates of $0.67, according to data compiled by LSEG
PFE's Q1 revenue misses estimates due to declining sales of its Paxlovid COVID-19 treatment, but co still sticks by FY revenue forecast of $61 billion-$64 billion
*Co says it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations
Including session's moves, PFE has fallen about 10% YTD